Re: Final Results of an EORTC-GU Cancers Group Randomized Study of Maintenance Bacillus Calmette-Guérin in Intermediate- and High-Risk Ta, T1 Papillary Carcinoma of the Urinary Bladder: One-Third Dose versus Full Dose and 1 Year versus 3 Years of Maintenance

J. Oddens, M. Brausi, R. Sylvester, A. Bono, C. van de Beek, G. van Andel, P. Gontero, W. Hoeltl, L. Turkeri, S. Marreaud, S. Collette and W. Oosterlinck Department of Urology, Jeroen Bosch Ziekenhuis, 's-Hertogenbosch, The Netherlands

Source: The Journal of Urology - October 30, 2013 Category: Urology & Nephrology Authors: David P. Wood Tags: Urological Oncology: Bladder, Penis and Urethral Cancer, and Basic Principles of Oncology Source Type: research